SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001078782-16-003325
Filing Date
2016-08-22
Accepted
2016-08-22 17:22:03
Documents
6
Period of Report
2016-08-19
Effectiveness Date
2016-08-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE 14A PROXY STATEMENT def14a081916_def14a.htm DEF 14A 560221
2 IMAGE def14a081916_def14a001.jpg GRAPHIC 247059
3 IMAGE def14a081916_def14a002.jpg GRAPHIC 238695
4 IMAGE def14a081916_def14a003.jpg GRAPHIC 134929
5 IMAGE def14a081916_def14a004.jpg GRAPHIC 214813
6 IMAGE def14a081916_def14a005.jpg GRAPHIC 99990
  Complete submission text file 0001078782-16-003325.txt   1850071
Mailing Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208
Business Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36833 | Film No.: 161845989
SIC: 2835 In Vitro & In Vivo Diagnostic Substances